Journal
GLOBAL HEART
Volume 17, Issue 1, Pages -Publisher
UBIQUITY PRESS LTD
DOI: 10.5334/gh.1098
Keywords
ischemic heart disease; mesenchymal stem cells; cardiac regeneration
Categories
Ask authors/readers for more resources
Cell-based therapeutics, particularly using mesenchymal stem cells, shows promising potential for regenerating the heart and treating ischemic heart disease, with successful pre-clinical and clinical trial results.
Although tremendous progress has been made in conventional treatment for ischemic heart disease, it still remains a major cause of death and disability. Cell-based therapeutics holds an exciting frontier of research for complete cardiac recuperation. The capacity of diverse stem and progenitor cells to stimulate cardiac renewal has been analysed, with promising results in both pre-clinical and clinical trials. Mesenchymal stem cells have been ascertained to have regenerative ability via a variety of mechanisms, including differentiation from the mesoderm lineage, immunomodulatory properties, and paracrine effects. Also, their availability, maintenance, and ability to replenish endogenous stem cell niches have rendered them suitable for front-line research. This review schemes to outline the use of mesenchymal stem cell therapeutics for ischemic heart disease, their characteristics, the potent mechanisms of mesenchymal stem cell-based heart regeneration, and highlight preclinical data. Additionally, we discuss the results of the clinical trials to date as well as ongoing clinical trials on ischemic heart disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available